rs225010

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_013989.5(DIO2):​c.223-2648G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.509 in 151,844 control chromosomes in the GnomAD database, including 20,649 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 20649 hom., cov: 31)

Consequence

DIO2
NM_013989.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.320

Publications

7 publications found
Variant links:
Genes affected
DIO2 (HGNC:2884): (iodothyronine deiodinase 2) The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the conversion of prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4) to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by outer ring 5'-deiodination. This gene is widely expressed, including in thyroid and brain. It is thought to be responsible for the 'local' production of T3, and thus important in influencing thyroid hormone action in these tissues. It has also been reported to be highly expressed in thyroids of patients with Graves disease, and in follicular adenomas. The intrathyroidal T4 to T3 conversion by this enzyme may contribute significantly to the relative increase in thyroidal T3 production in these patients. This protein is a selenoprotein containing the non-standard amino acid, selenocysteine (Sec), which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Unlike the other two members (DIO1 and DIO3) of this enzyme family, the mRNA for this gene contains an additional in-frame UGA codon that has been reported (in human) to function either as a Sec or a stop codon, which can result in two isoforms with one or two Sec residues; however, only the upstream Sec (conserved with the single Sec residue found at the active site in DIO1 and DIO3) was shown to be essential for enzyme activity (PMID:10403186). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2018]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.718 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIO2NM_013989.5 linkc.223-2648G>A intron_variant Intron 1 of 1 ENST00000438257.9 NP_054644.1 Q92813-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIO2ENST00000438257.9 linkc.223-2648G>A intron_variant Intron 1 of 1 1 NM_013989.5 ENSP00000405854.5 Q92813-1

Frequencies

GnomAD3 genomes
AF:
0.509
AC:
77180
AN:
151726
Hom.:
20614
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.648
Gnomad AMI
AF:
0.403
Gnomad AMR
AF:
0.527
Gnomad ASJ
AF:
0.488
Gnomad EAS
AF:
0.738
Gnomad SAS
AF:
0.546
Gnomad FIN
AF:
0.382
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.423
Gnomad OTH
AF:
0.494
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.509
AC:
77271
AN:
151844
Hom.:
20649
Cov.:
31
AF XY:
0.509
AC XY:
37768
AN XY:
74190
show subpopulations
African (AFR)
AF:
0.648
AC:
26838
AN:
41424
American (AMR)
AF:
0.528
AC:
8047
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.488
AC:
1695
AN:
3470
East Asian (EAS)
AF:
0.737
AC:
3804
AN:
5158
South Asian (SAS)
AF:
0.546
AC:
2627
AN:
4810
European-Finnish (FIN)
AF:
0.382
AC:
4022
AN:
10532
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.423
AC:
28711
AN:
67896
Other (OTH)
AF:
0.495
AC:
1043
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1844
3689
5533
7378
9222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
4677
Bravo
AF:
0.528
Asia WGS
AF:
0.667
AC:
2318
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.6
DANN
Benign
0.50
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs225010; hg19: chr14-80672279; API